McAvoy David R.
- SEC CIK
- 0001758842
No open-market purchases or sales filed in the past year.
Current role at each company
- TEVA Teva Pharmaceutical Industries LtdEVP, Chief Legal Officeras of Sep 9, 2025
- FRTX Fresh Tracks Therapeutics, Inc.Gen Counsel, CCO, & Secretaryas of Oct 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McAvoy David R. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TEVA Teva Pharmaceutical Industries Ltd
EVP, Chief Legal Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 (view filing) | Sep 5 | 4 days | McAvoy David R.EVP, Chief Legal Officer | PPurchase | +1.11K | $18.86 | +$21.0K | +9.3%13.0K after | |
| Mar 6, 2025 (view filing) | Mar 4-5 | 2 days | McAvoy David R.EVP, Chief Legal Officer | SSale | −4.83K | $15.79 | −$76.2K | −28.8%11.9K after | 2 lots10b5-1 |
FRTX Fresh Tracks Therapeutics, Inc.
Gen Counsel, CCO, & Secretary1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 (view filing) | Jul 23 | 4 days | McAvoy David R.General Counsel and CCO | PPurchase | +18.1K | $0.67 | +$12.1K | +16.4%128.9K after |